Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from TYK Medicines, Inc. Class H ( (HK:2410) ).
TYK Medicines, Inc, a joint stock company incorporated in the People’s Republic of China, has submitted an application to the China Securities Regulatory Commission (CSRC) for the conversion of 4,608,000 unlisted shares into H shares. This move aims to list these shares on the Stock Exchange of Hong Kong Limited as part of the H Share Full Circulation initiative. The conversion is contingent upon receiving necessary approvals from relevant regulatory authorities. This development is significant as it could enhance the liquidity of the company’s shares and potentially improve its market positioning.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 2,113,850
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$8.48B
For detailed information about 2410 stock, go to TipRanks’ Stock Analysis page.